ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 232 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2021. The put-call ratio across all filers is 8.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,163,809 | -25.3% | 621,706 | -3.3% | 0.01% | -16.7% |
| Q2 2023 | $29,660,928 | +13.5% | 642,986 | -1.3% | 0.01% | 0.0% |
| Q1 2023 | $26,133,564 | -13.5% | 651,710 | -0.0% | 0.01% | -14.3% |
| Q4 2022 | $30,195,300 | -0.9% | 651,744 | -11.4% | 0.01% | 0.0% |
| Q3 2022 | $30,465,000 | -35.7% | 735,710 | -7.3% | 0.01% | -36.4% |
| Q2 2022 | $47,371,000 | -13.6% | 794,032 | +5.2% | 0.01% | 0.0% |
| Q1 2022 | $54,829,000 | -23.2% | 755,032 | -11.1% | 0.01% | -15.4% |
| Q4 2021 | $71,438,000 | -8.4% | 849,543 | -1.7% | 0.01% | -13.3% |
| Q3 2021 | $77,954,000 | -4.9% | 864,345 | +0.5% | 0.02% | -6.2% |
| Q2 2021 | $81,989,000 | -12.4% | 859,857 | +4.6% | 0.02% | -15.8% |
| Q1 2021 | $93,582,000 | -10.9% | 821,915 | +8.3% | 0.02% | -17.4% |
| Q4 2020 | $105,016,000 | +65.4% | 758,632 | -1.8% | 0.02% | +43.8% |
| Q3 2020 | $63,482,000 | +7.5% | 772,389 | +2.3% | 0.02% | 0.0% |
| Q2 2020 | $59,068,000 | +88.7% | 755,149 | +7.2% | 0.02% | +60.0% |
| Q1 2020 | $31,297,000 | +217.5% | 704,416 | +205.2% | 0.01% | +233.3% |
| Q4 2019 | $9,858,000 | +1.8% | 230,818 | +2.0% | 0.00% | 0.0% |
| Q3 2019 | $9,679,000 | -33.2% | 226,246 | -0.9% | 0.00% | -25.0% |
| Q2 2019 | $14,491,000 | -8.6% | 228,206 | -0.2% | 0.00% | 0.0% |
| Q1 2019 | $15,863,000 | +75.5% | 228,694 | +10.0% | 0.00% | +33.3% |
| Q4 2018 | $9,040,000 | -42.9% | 207,926 | +0.3% | 0.00% | -25.0% |
| Q3 2018 | $15,822,000 | -0.9% | 207,265 | -0.2% | 0.00% | 0.0% |
| Q2 2018 | $15,963,000 | +53.6% | 207,662 | +1.9% | 0.00% | +33.3% |
| Q1 2018 | $10,391,000 | +27.6% | 203,759 | +16.0% | 0.00% | +50.0% |
| Q4 2017 | $8,146,000 | -16.2% | 175,617 | -3.8% | 0.00% | -33.3% |
| Q3 2017 | $9,723,000 | -11.0% | 182,572 | +3.8% | 0.00% | 0.0% |
| Q2 2017 | $10,921,000 | -13.1% | 175,836 | -5.2% | 0.00% | 0.0% |
| Q1 2017 | $12,574,000 | +2.2% | 185,512 | +6.0% | 0.00% | -25.0% |
| Q4 2016 | $12,309,000 | +5.3% | 175,062 | +6.2% | 0.00% | +33.3% |
| Q3 2016 | $11,695,000 | +39.5% | 164,876 | -3.8% | 0.00% | 0.0% |
| Q2 2016 | $8,385,000 | -25.1% | 171,436 | -3.0% | 0.00% | 0.0% |
| Q1 2016 | $11,191,000 | -43.4% | 176,769 | +0.2% | 0.00% | -50.0% |
| Q4 2015 | $19,781,000 | +17.5% | 176,336 | +0.9% | 0.01% | +20.0% |
| Q3 2015 | $16,833,000 | -2.4% | 174,780 | +3.8% | 0.01% | 0.0% |
| Q2 2015 | $17,248,000 | +240.1% | 168,448 | +106.2% | 0.01% | +400.0% |
| Q1 2015 | $5,071,000 | +77.6% | 81,677 | +25.6% | 0.00% | 0.0% |
| Q4 2014 | $2,855,000 | -45.4% | 65,050 | -29.6% | 0.00% | 0.0% |
| Q3 2014 | $5,229,000 | +94.4% | 92,384 | +54.2% | 0.00% | – |
| Q2 2014 | $2,690,000 | +183.8% | 59,920 | +209.0% | 0.00% | – |
| Q1 2014 | $948,000 | – | 19,389 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |